Ticker

Analyst Price Targets — AVNS

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 30, 2024 3:10 pmRick WiseStifel Nicolaus$20.00$18.58StreetInsider Avanos Medical (AVNS) PT Lowered to $20 at Stifel
January 6, 2023 8:50 amMorgan Stanley$26.00$26.99Benzinga Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $26
July 18, 2022 9:35 amStifel Nicolaus$28.00$26.89Benzinga Stifel Maintains Hold on Avanos Medical, Lowers Price Target to $28
July 15, 2022 9:38 amMorgan Stanley$28.00$27.19Benzinga Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $28
May 5, 2022 7:56 amMorgan Stanley$33.00$29.29Benzinga Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $33

Latest News for AVNS

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is…

Business Wire • Jun 24, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for AVNS.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top